Sponsored by:

Nuclear Medicine: Page 401

For thyroid applications, iodine-123 looks great, less stunning
Research indicates that the use of iodine-131, generally considered the gold standard for thyroid cancer diagnosis, may actually have a negative impact on treatment outcomes. As a result, investigators are turning to iodine-123 as a potential alternative.
October 20, 2002
2002 10 18 10 42 32 706
EBCT proves complementary to SPECT stress tests for gauging coronary artery blockage
In patients with equivocal radionuclide stress test results, electron-beam CT could be the back-up modality of choice for diagnosing obstructive coronary artery disease, particularly because of its prognostic power.
October 20, 2002
NAS adds to executive roster
Radiopharmaceutical developer North American Scientific (NAS) has made two appointments to its sales and marketing management team.
October 2, 2002
Cardiolite helps find early-stage CAD in diabetics
By AuntMinnie.com staff writers
The cardiac radiopharmaceutical Cardiolite has shown promise in detecting early-stage coronary artery disease in diabetes patients who don’t have symptoms of the disease, according to clinical results presented at this week’s American Society of Nuclear Cardiology meeting in Baltimore.
October 2, 2002
Nuclear medicine sheds lights on cardiovascular disease in women
Myocardial perfusion imaging should play a bigger role in evaluating women with known or suspected heart disease, according to Dr. Jennifer Mieres, the director of nuclear cardiology at the North Shore University Hospital in Manhasset, NY. Mieres believes that the burden of heart disease falls disproportionately on women.
October 2, 2002
Syncor, MSU to offer PET cyclotron
By AuntMinnie.com staff writers
Radiopharmaceutical provider Syncor International and Michigan State University have signed an agreement to launch a cyclotron service for western Michigan.
October 1, 2002
Siemens adds music, video capabilities to nuclear line
By AuntMinnie.com staff writers
Care for a little Frodo Baggins with your FDG-PET?
September 30, 2002
Palatin’s revenues down, losses up in fiscal 2002
By AuntMinnie.com staff writers
Palatin Technologies have reported fourth quarter and fiscal year 2002 (end-June 30) results.
September 30, 2002
Mobile PET turns in revenue gains in 2002
By AuntMinnie.com staff writers
Mobile PET Systems reported fiscal 2002 revenues of $17.6 million, up approximately 145% compared with the $7.2 million posted in fiscal 2001.
September 30, 2002
Referring physicians reserve perfusion imaging for sickest patients
BALTIMORE - Coronary artery disease patients with the most serious symptoms are more likely to wind up in the nuclear medicine imaging department, resulting in skewed referral patterns, according to a presentation at the American Society of Nuclear Cardiology meeting.
September 29, 2002
PET advocates urge CMS to rethink proposed reimbursement rates
By Kate Madden Yee
Less than six months after raising Medicare reimbursement rates for FDG-PET procedures, the Centers for Medicare and Medicaid Services (CMS) has recommended significantly lower rates for 2003, sparking a flurry of activity among PET proponents to educate CMS on the true cost of PET.
September 29, 2002
Wait time reduced with new rest-stress test protocol
BALTIMORE - Imaging specialists performing the standard technetium-99m sestamibi stress protocol may not need to wait three hours between tests to allow for the breakdown of sestamibi, according to a poster presented Thursday at the American Society of Nuclear Cardiology conference.
September 26, 2002
Previous Page
Page 401 of 440
Next Page